Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia
Gerwyn Morris, Luba Sominsky, Kenneth R. Walder, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3485-3503
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder
Cong-Ya Chen, Yufei Wang, Lan Lei, et al.
Life Sciences (2024) Vol. 351, pp. 122815-122815
Closed Access | Times Cited: 19
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110626-110626
Closed Access | Times Cited: 59
Novel potential pharmacological applications of dimethyl fumarate—an overview and update
Giorgia Bresciani, Federico Manai, Sergio Davinelli, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 27
Systemic inflammation and oxidative stress markers in patients with unipolar and bipolar depression: A large-scale study
YanYan Wei, Huanqin Gao, Yanhong Luo, et al.
Journal of Affective Disorders (2023) Vol. 346, pp. 154-166
Closed Access | Times Cited: 23
Neuroinflammation and schizophrenia – is there a link?
Cristiano Chaves, Serdar Dursun, Massimo Tusconi, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Redefining Autoimmune Disorders’ Pathoetiology: Implications for Mood and Psychotic Disorders’ Association with Neurodegenerative and Classical Autoimmune Disorders
George Anderson, Abbas F. Almulla, Russel J. Reıter, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1237-1237
Open Access | Times Cited: 14
Schizophrenia and oxidative stress from the perspective of bibliometric analysis
Meng-Yi Chen, Qinge Zhang, Yufei Liu, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 12
Changes in Inflammatory Biomarkers in Patients with Schizophrenia: A 3-Year Retrospective Study
Xiaoyu Zhu, Ran Li, Yu Zhu, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1597-1604
Open Access | Times Cited: 11
Microglial cannabinoid receptor 2 and epigenetic regulation: implications for the treatment of depression
Priyanka Sharma, Rajni Daksh, Saumya Khanna, et al.
European Journal of Pharmacology (2025), pp. 177422-177422
Open Access
Investigating Cannabidiol’s Potential as a Supplementary Treatment for Schizophrenia: A Narrative Review
Jes Sebastian Denis Völker, I. Micluția, Ramona-Cristina Vinași
European Journal of Pharmacology (2024) Vol. 979, pp. 176821-176821
Closed Access | Times Cited: 3
The Burden of Psychiatric Manifestations in Inflammatory Bowel Diseases: A Systematic Review With Meta-analysis
Sara Massironi, Alessandro Pigoni, Elena Vegni, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 3
Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway
Marjan Talebi, Mohammad Mehdi Sadoughi, Seyed Abdulmajid Ayatollahi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115805-115805
Open Access | Times Cited: 8
Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models
Luana B. Domingos, Nicole Rodrigues da Silva, Adriano José Maia Chaves Filho, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 13
Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain
Adriana Della Pietra, Juha R. Savinainen, Rashid Giniatullin
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4407-4407
Open Access | Times Cited: 12
Advances in the gut microbiome and mood disorders
Sabrina Mörkl, Mary I. Butler, Sonja Lackner
Current Opinion in Psychiatry (2022) Vol. 36, Iss. 1, pp. 1-7
Closed Access | Times Cited: 12
THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation
Nicolás Lamanna‐Rama, Diego Romero‐Miguel, Marta Casquero‐Veiga, et al.
Psychiatry Research (2023) Vol. 331, pp. 115643-115643
Closed Access | Times Cited: 3
Emerging mechanisms by which endocannabinoids and their derivatives modulate bacterial populations within the gut microbiome
Melissa Ellermann
Advances in Drug and Alcohol Research (2023) Vol. 3
Open Access | Times Cited: 3
A Potential Immune-Related miRNAs Regulatory Network and Corresponding Diagnostic Efficacy in Schizophrenia
Fangping Liao, Qingqing Zhong, Xueying Liang, et al.
Neurochemical Research (2023) Vol. 48, Iss. 9, pp. 2784-2793
Closed Access | Times Cited: 2
Function and mechanism exploring of icariin in schizophrenia through network pharmacology
Bing Liu, Chengqiang Wang, Ruyuan Liu, et al.
Brain Research (2024) Vol. 1835, pp. 148931-148931
Closed Access
Biomarkers
Margareth Borges Coutinho Gallo
(2024), pp. 13-36
Closed Access
Hypotheses of the Pathophysiology of Schizophrenia Spectrum Disorders
Margareth Borges Coutinho Gallo
(2024), pp. 1-12
Closed Access
Physical Exercise Improves the Neuronal Function in Ischemic Stroke Via Microglial CB2R/P2Y12 Signaling
Xiaofei He, Xiaofeng Yang, Ge Li, et al.
Molecular Neurobiology (2024)
Closed Access
Yinxieling attenuates psoriasis in mice by regulating oxidative stress and lipid mediators to correct immune cell disorder through the NF-κB/Nrf2 signaling pathways
Qihua Yu, Jun-An Ke, Baolin Xie, et al.
Journal of Traditional and Complementary Medicine (2024)
Open Access
Role of anandamide in Alzheimer's disease
Dina Medina‐Vera, Simone Tambaro
Elsevier eBooks (2024), pp. 419-443
Closed Access
Activation of the endocannabinoid system in schizophrenia: A compensatory mechanism of subclinical inflammation?
Błażej Misiak, Tomasz Bielawski, Jerzy Samochowiec, et al.
Schizophrenia Research (2023) Vol. 252, pp. 67-68
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top